Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

92.51 +0.62 (+0.67%)
Official Closing Price Updated: 6:30 PM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,657,056
Open 92.31
Bid (Size) 91.86 (1)
Ask (Size) 93.00 (1)
Prev. Close 91.89
Today's Range 91.89 - 92.98
52wk Range 70.89 - 95.72
Shares Outstanding 2,531,374,696
Dividend Yield 2.81%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
This Analyst Believes Seagen Is Evaluating Strategic Alternatives
 
Via Benzinga
What Are Whales Doing With Merck & Co
A whale with a lot of money to spend has taken a noticeably bullish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 11 strange trades. 
Via Benzinga

Performance

YTD
+20.35%
+20.35%
1 Month
+0.52%
+0.52%
3 Month
+13.41%
+13.41%
6 Month
+20.44%
+20.44%
1 Year
+20.36%
+20.36%

More News

Read More
Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market
From Merck & Co., Inc.
Via Business Wire
Merck to Hold Second-Quarter 2022 Sales and Earnings Conference Call July 28
From Merck & Co., Inc.
Via Business Wire
8 Analysts Have This to Say About Merck & Co
Via Benzinga
Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ
Via Benzinga
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Via Benzinga
Tesla To $1,150? Here's The Biggest Price Target Changes For Monday
Via Benzinga
LYNPARZA® (olaparib) Receives Positive Opinion From EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer
From Merck & Co., Inc.
Via Business Wire
EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies
Via Benzinga
3 Dow Stocks to Buy for a Bear Market
Via InvestorPlace
Seagen Surges As Merck Takeover Deal Reportedly Accelerating
Via Investor's Business Daily
Benzinga Before The Bell: Gun Safety Bill. Bill Gates's North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24
Via Benzinga
European Commission Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent Patients (≥12 Years of Age) With Stage IIB or IIC Melanoma Following Complete Resection
From Merck & Co., Inc.
Via Business Wire
Merck & Co Whale Trades For June 23
Via Benzinga
6 Dividend Income Stocks With Better Yields Than the S&P 500
Via InvestorPlace
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Via Benzinga
CDC’s ACIP Unanimously Votes to Provisionally Recommend Use of Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) as an Option for Pneumococcal Vaccination in Infants and Children
From Merck & Co., Inc.
Via Business Wire
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
Via InvestorPlace
U.S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children
From Merck & Co., Inc.
Via Business Wire
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Via Benzinga
Results From Phase 3 PROpel Trial of LYNPARZA® (olaparib) Plus Abiraterone in First-Line Metastatic Castration-Resistant Prostate Cancer Published in NEJM Evidence
From Merck & Co., Inc.
Via Business Wire
Merck Announces that Chirfi Guindo will Lead Marketing for Merck Human Health
From Merck & Co., Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.